Outcomes following hematopoietic cell transplantation for children, adolescents and young adults with relapsed acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: Outcomes following hematopoietic cell transplantation for children, adolescents and young adults with relapsed acute lymphoblastic leukemia.
Authors: Summers C; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington. Electronic address: corinne.summers@seattlechildrens.org., Mallhi K; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington., Persinger H; Fred Hutchinson Cancer Center, Seattle, Washington., Fan X; Fred Hutchinson Cancer Center, Seattle, Washington., Gooley TA; Fred Hutchinson Cancer Center, Seattle, Washington., Dahlberg AE; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington., Burroughs LM; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington., Thakar MS; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington., Bhatt NS; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington., Petrovic A; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington., Hadland B; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington., Carpenter PA; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington., Baker KS; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington., Bleakley M; Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington; Cancer and Blood Disorders, Seattle Children's Hospital, Seattle, Washington.
Source: Cytotherapy [Cytotherapy] 2026 Mar; Vol. 28 (3), pp. 102004. Date of Electronic Publication: 2025 Nov 16.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1477-2566
DOI:10.1016/j.jcyt.2025.102004